PNEUMOCOCCAL VACCINES
Clinical trials for PNEUMOCOCCAL VACCINES explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL VACCINES trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL VACCINES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine aims to outsmart pneumonia: VAX-31 trial launches
⭐️ VACCINE ⭐️ OngoingThis study tests a new vaccine called VAX-31 to prevent pneumococcal disease (like pneumonia) in healthy adults aged 50 and older, and also checks if it works similarly in younger adults aged 18-49. About 4,000 participants will receive either VAX-31 or an existing vaccine to com…
Matched conditions: PNEUMOCOCCAL VACCINES
Phase: PHASE3 • Sponsor: Vaxcyte, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 13:52 UTC
-
New pneumonia vaccine VAX-31 shows promise in phase 3 trial for older adults
⭐️ VACCINE ⭐️ OngoingThis study tests a new vaccine called VAX-31 in 752 healthy adults aged 50 and older who have already received a pneumonia vaccine. The goal is to see if VAX-31 is safe and triggers a strong immune response. Participants receive either VAX-31 or an existing vaccine, and researche…
Matched conditions: PNEUMOCOCCAL VACCINES
Phase: PHASE3 • Sponsor: Vaxcyte, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 19, 2026 11:49 UTC
-
New infant vaccine VAX-31 aims to outshine current pneumococcal shot
⭐️ VACCINE ⭐️ OngoingThis study tests a new vaccine called VAX-31 in healthy infants to see if it safely protects against pneumococcal infections better than the current vaccine. Around 900 babies will receive four doses at 2, 4, 6, and 12-15 months old, alongside their routine shots. Researchers wil…
Matched conditions: PNEUMOCOCCAL VACCINES
Phase: PHASE2 • Sponsor: Vaxcyte, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 18, 2026 12:04 UTC
-
New combo shot study: could one visit protect against 31 pneumonia strains and flu?
Prevention OngoingThis study tests a new vaccine called VAX-31, which targets 31 types of bacteria that cause pneumonia and other infections. Researchers want to see if it is safe and works well when given at the same time as the seasonal flu shot in healthy adults aged 50 and older. About 1,390 p…
Matched conditions: PNEUMOCOCCAL VACCINES
Phase: PHASE3 • Sponsor: Vaxcyte, Inc. • Aim: Prevention
Last updated May 07, 2026 18:41 UTC